Page last updated: 2024-08-17

apomorphine and Ambulation Disorders, Neurologic

apomorphine has been researched along with Ambulation Disorders, Neurologic in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (25.00)	29.6817
2010's	6 (75.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chaudhuri, KR; Deuschl, G; Henriksen, T; Katzenschlager, R; Lees, A; Poewe, W; Rascol, O; Spivey, K; Staines, H; Trenkwalder, C; van Laar, T; Vel, S	1
Krauss, JK; Lütjens, G; Schwabe, K	1
Chen, JJ; Chen, LH; Chiang, PT; Hsieh, TH; Lee, HY	1
Binder, EB; Cáceda, R; Kinkead, B; Nemeroff, CB	1
Carey, RJ; Carrera, MP; de Matos, LW; Dias, FR; Sampaio, Mde F	1
Döbrössy, MD; García, J; Kaindlstorfer, C; Nikkhah, G; Wenning, GK; Winkler, C	1
Barr, AM; Geyer, MA; Markou, A; Powell, SB	1
Bouchard, K; Hohnadel, E; Terry, AV	1

Trials

1 trial(s) available for apomorphine and Ambulation Disorders, Neurologic

Article	Year
Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial. The Lancet. Neurology, 2018, Volume: 17, Issue:9 Topics: Age Factors; Aged; Analysis of Variance; Antiparkinson Agents; Apomorphine; Double-Blind Method; Female; Gait Disorders, Neurologic; Humans; Infusions, Subcutaneous; Longitudinal Studies; Male; Middle Aged; Parkinson Disease; Severity of Illness Index; Time Factors; Treatment Outcome	2018

Article

Year

Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial.

The Lancet. Neurology, 2018, Volume: 17, Issue:9

Topics: Age Factors; Aged; Analysis of Variance; Antiparkinson Agents; Apomorphine; Double-Blind Method; Female; Gait Disorders, Neurologic; Humans; Infusions, Subcutaneous; Longitudinal Studies; Male; Middle Aged; Parkinson Disease; Severity of Illness Index; Time Factors; Treatment Outcome

2018

Other Studies

7 other study(ies) available for apomorphine and Ambulation Disorders, Neurologic

Article	Year
Lesions of the entopeduncular nucleus in rats prevent apomorphine-induced deficient sensorimotor gating. Behavioural brain research, 2011, Jul-07, Volume: 220, Issue:2 Topics: Acoustic Stimulation; Analysis of Variance; Animals; Apomorphine; Conditioning, Operant; Disease Models, Animal; Disease Progression; Dopamine Agonists; Entopeduncular Nucleus; Gait Disorders, Neurologic; Inhibition, Psychological; Male; Maze Learning; Motor Activity; Rats; Rats, Sprague-Dawley; Reflex, Startle; Rotarod Performance Test	2011
Time-course gait analysis of hemiparkinsonian rats following 6-hydroxydopamine lesion. Behavioural brain research, 2011, Sep-12, Volume: 222, Issue:1 Topics: Analysis of Variance; Animals; Apomorphine; Disease Models, Animal; Disease Progression; Functional Laterality; Gait Disorders, Neurologic; Male; Medial Forebrain Bundle; Movement; Oxidopamine; Parkinsonian Disorders; Psychomotor Performance; Rats; Rats, Wistar; Stereotyped Behavior; Sympatholytics; Time Factors; Tyrosine 3-Monooxygenase; Videotape Recording	2011
The role of endogenous neurotensin in psychostimulant-induced disruption of prepulse inhibition and locomotion. Schizophrenia research, 2012, Volume: 136, Issue:1-3 Topics: Acoustic Stimulation; Adamantane; Amphetamine; Analysis of Variance; Animals; Apomorphine; Behavior, Animal; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Gait Disorders, Neurologic; Gene Expression Regulation; Imidazoles; Male; Neurotensin; Proto-Oncogene Proteins c-fos; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Receptors, Neurotensin; Reflex, Startle; RNA, Messenger	2012
Opposite effects of low versus high dose haloperidol treatments on spontaneous and apomorphine induced motor behavior: evidence that at a very low dose haloperidol acts as an indirect dopamine agonist. Behavioural brain research, 2012, Apr-01, Volume: 229, Issue:1 Topics: Analysis of Variance; Animals; Antipsychotic Agents; Apomorphine; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Gait Disorders, Neurologic; Haloperidol; Locomotion; Male; Rats; Rats, Wistar; Time Factors	2012
Behavioral and histological analysis of a partial double-lesion model of parkinson-variant multiple system atrophy. Journal of neuroscience research, 2012, Volume: 90, Issue:6 Topics: Animals; Apomorphine; Cell Count; Corpus Striatum; Disease Models, Animal; Dopamine Agonists; Dopamine and cAMP-Regulated Phosphoprotein 32; Exploratory Behavior; Female; Functional Laterality; Gait Disorders, Neurologic; Motor Activity; Multiple System Atrophy; Oxidopamine; Parkinson Disease; Psychomotor Performance; Quinolinic Acid; Rats; Rats, Sprague-Dawley; Tyrosine 3-Monooxygenase	2012
Iloperidone reduces sensorimotor gating deficits in pharmacological models, but not a developmental model, of disrupted prepulse inhibition in rats. Neuropharmacology, 2006, Volume: 51, Issue:3 Topics: Acoustic Stimulation; Adrenergic alpha-Agonists; Analysis of Variance; Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Disease Models, Animal; Dopamine Agonists; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Drug Interactions; Excitatory Amino Acid Antagonists; Gait Disorders, Neurologic; Imidazoles; Isoxazoles; Male; Neural Inhibition; Phencyclidine; Piperidines; Rats; Rats, Sprague-Dawley; Reflex, Startle	2006
Galantamine and donepezil attenuate pharmacologically induced deficits in prepulse inhibition in rats. Neuropharmacology, 2007, Volume: 52, Issue:2 Topics: Acoustic Stimulation; Analysis of Variance; Animals; Apomorphine; Behavior, Animal; Dizocilpine Maleate; Donepezil; Dose-Response Relationship, Drug; Drug Interactions; Gait Disorders, Neurologic; Galantamine; Indans; Inhibition, Psychological; Male; Nootropic Agents; Piperidines; Rats; Reflex, Startle; Scopolamine	2007